SCTL Block Holds Its Own Against Thoracic Paravertebral Analgesia After Nephrectomy
In a prospective randomized non-inferiority trial, ultrasound-guided superior costotransverse ligament block performed as well as thoracic paravertebral block for early postoperative pain control after laparoscopic nephrectomy. The study asked a practical question for anesthesiologists: can a more superficial injection target deliver comparable analgesia without exposing patients to the pleural proximity inherent to a paravertebral approach?
The answer was yes, at least by the study’s prespecified pain endpoint. Both techniques were paired with standardized general anesthesia and morphine-based patient-controlled intravenous analgesia, so the comparison focused on the regional block itself rather than on uneven background care. Pain was measured as peak cough-evoked numerical rating scale score two hours after skin closure, a moment when even modest parietal or incisional discomfort can become clinically obvious during deep breathing and coughing.
The primary result was tightly aligned between groups. In the per-protocol population of 72 patients, the between-group difference in pain score, calculated as SCTL minus TPVB, was 0.056 with a 95% confidence interval from −0.341 to 0.452. In the intention-to-treat analysis of 76 patients, the difference was 0.12 with a 95% confidence interval from −0.27 to 0.51. Both upper confidence bounds stayed below the predefined non-inferiority margin of 1.0, which supported non-inferiority for the new block.
Pain Control Without a Performance Gap
The absence of a clinically meaningful gap matters because laparoscopic nephrectomy is not a trivial analgesic setting. Although minimally invasive surgery reduces incision size, the operation still irritates the diaphragm, upper abdominal wall, and thoracic dermatomes, producing sharp pain with movement and cough. In that context, a regional technique that preserves respiration-friendly analgesia can reduce reliance on escalating opioids and the sedation, nausea, and delayed mobilization that often follow.
The cohort was small but not trivial for a procedural anesthesia study. Of 78 screened patients, 76 were randomized and 72 completed the per-protocol analysis, with 36 patients in each group. The investigators used a 0.4 mL/kg dose of 0.5% ropivacaine at T10 in both arms, a design that keeps local anesthetic exposure aligned and allows the anatomy of the injection plane to do the real work.
One pneumothorax occurred in the thoracic paravertebral group, and none occurred in the superior costotransverse ligament group. Even in a modest sample, that asymmetry will catch the attention of clinicians who perform single-shot thoracic blocks near the pleura. The result does not establish a safety advantage, but it does fit the anatomic logic of the two approaches: the paravertebral target lies closer to the pleural boundary, while the superior costotransverse ligament plane offers a more superficial route into the thoracic region.
Why a Superficial Thoracic Plane May Be Enough
The appeal of the superior costotransverse ligament approach is not cosmetic. The thoracic paravertebral space remains effective because it can spread local anesthetic near the spinal nerves as they exit the vertebral column, but that same depth creates procedural complexity and leaves little margin for error. By contrast, an injection over the superior costotransverse ligament may capture thoracic analgesic pathways while reducing direct pleural exposure, which is exactly the kind of anatomical compromise regional anesthesiologists look for when balancing efficacy and risk.
Ropivacaine was a rational agent for both blocks. Its sensory-selective profile supports postoperative analgesia while limiting motor impairment, a useful feature after abdominal surgery when early ambulation and respiratory effort matter. The study design also mirrors how these procedures are used in real practice: a single regional intervention layered onto general anesthesia and systemic rescue analgesia, not a stand-alone anesthetic strategy.
The comparison is especially relevant because postoperative pain after nephrectomy is often underestimated once the surgery is labeled laparoscopic. Patients still need to cough, breathe deeply, and move, and thoracic wall pain can undermine all three. When cough-evoked pain falls, the bedside consequences are concrete: better pulmonary toilet, less splinting, and a smaller immediate burden of rescue analgesics.
Safety Signal, Narrow Evidence Base
The trial was not powered to settle comparative safety. The low adverse-event count and the small sample size make that limit unavoidable. A single pneumothorax in the thoracic paravertebral arm is clinically meaningful for the patient who experienced it, but it is not enough to quantify a true difference in complication rates between techniques.
The confidence intervals also deserve attention. Although they confirm non-inferiority for the pain endpoint, they do not tell anesthesiologists whether one block is better for secondary outcomes such as opioid consumption, nausea, respiratory mechanics, or recovery quality, because those details were not provided in the abstracted material here. Without those data, the most defensible conclusion stays narrow: the superior costotransverse ligament block achieved analgesia comparable to thoracic paravertebral block on the predefined primary endpoint.
The trial was prospectively registered at ChiCTR2300075992 and conducted with ethics approval and informed consent, which strengthens confidence in the procedural rigor. Randomized non-inferiority trials in regional anesthesia are especially useful when the clinical question is not whether a new block can outperform an established one, but whether it can match it while simplifying access to the target plane or reducing anatomic hazard.
For bedside practice, the study keeps the discussion focused on technique selection rather than analgesic ideology. If a thoracic block can be delivered through a safer-appearing plane without losing early pain control, that option deserves serious consideration in laparoscopic nephrectomy cases, especially in patients for whom pleural injury would be particularly undesirable. The remaining question is safety precision: larger studies will be needed before anyone can claim that the superficial target truly lowers complication rates rather than merely suggesting that possibility.